You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer

 

Online download statistics by month:

Online download statistics by month: February 2022 to April 2023

AbstractFullPdf
Feb 202217801831531
Mar 2022617628153
Apr 202226426956
May 202230032476
Jun 2022563574106
Jul 202237237645
Aug 202225425832
Sep 202221922547
Oct 202221421683
Nov 202221221551
Dec 202216116134
Jan 202315415648
Feb 202315615838
Mar 202312913140
Apr 202312012241
Total551556441381